OTCMKTS:IZOZF Izotropic (IZOZF) Stock Price, News & Analysis $0.18 -0.02 (-10.98%) As of 03:48 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Izotropic Stock (OTCMKTS:IZOZF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Izotropic alerts:Sign Up Key Stats Today's Range$0.18▼$0.2050-Day Range$0.14▼$0.2452-Week Range$0.02▼$0.33Volume23,470 shsAverage Volume36,124 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIzotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.Read More… Receive IZOZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Izotropic and its competitors with MarketBeat's FREE daily newsletter. Email Address IZOZF Stock News HeadlinesIzotropic to Present at Investor Conference February 6thFebruary 3, 2025 | globenewswire.comFiling Pre-Submission with U.S. FDA Sends Shares Of This Biotech HigherJanuary 10, 2025 | msn.comA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been crippled. Japan’s in the process of being crippled. And it seems Europe may be next. And despite the president insisting that the Fed reduce rates – and with Vice President J.D. Vance saying “the refusal by the Fed to cut rates is monetary malpractice” – the Fed has decided to hold rates steady once again.June 20, 2025 | Porter & Company (Ad)Izotropic to launch Izoview for breast cancer diagnosticsAugust 24, 2024 | msn.comIzotropic Corporation (1R3.F)April 18, 2024 | finance.yahoo.comIzotropic Receives Response From U.S. FDAJanuary 30, 2024 | finance.yahoo.comIzotropic Provides Regulatory and Operational UpdatesJanuary 8, 2024 | finance.yahoo.comIzotropic Corp IZONovember 11, 2023 | morningstar.comSee More Headlines IZOZF Stock Analysis - Frequently Asked Questions How have IZOZF shares performed this year? Izotropic's stock was trading at $0.0339 on January 1st, 2025. Since then, IZOZF shares have increased by 438.3% and is now trading at $0.1825. View the best growth stocks for 2025 here. How do I buy shares of Izotropic? Shares of IZOZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today6/20/2025Next Earnings (Estimated)8/25/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolOTCMKTS:IZOZF CIKN/A Webizocorp.com Phone833-496-2677FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (OTCMKTS:IZOZF) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis is your first (and maybe last) chanceGet in before Monday if you want true wealth. In the 46 year storied existence of Zacks Investment Research… ...Zacks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Izotropic Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Izotropic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
